SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
<< first | < prev
page:
of 3
|
records per page:
next >
| last >>
|
pages: 1 2 3
|
presentations:
1 to
50 of
111
|
PREVENTING HIV AMONG PEOPLE WHO INJECT DRUGS: PLUS ÇA CHANGE, PLUS ÇA MÊME CHOSE (ABSTRACT
62)
Steffanie A Strathdee
University of California San Diego, La Jolla, CA, USA
SEX DIFFERENCES IN HIV (ABSTRACT
63)
Eileen P Scully
Johns Hopkins University, Baltimore, MD, USA
A MENDELIAN RANDOMIZATION ANALYSIS OF PROTEIN BIOMARKERS AND CVD IN PERSONS WITH HIV (ABSTRACT
80)
Cavan Reilly
University of Minnesota, Minneapolis, MN, USA
RISKS OF METABOLIC SYNDROME, DIABETES, AND CARDIOVASCULAR DISEASE IN ADVANCE TRIAL (ABSTRACT
81)
Andrew Hill
University of Liverpool, Liverpool, United Kingdom
CYP2B6 GENOTYPE AND WEIGHT-GAIN DIFFERENCES BETWEEN DOLUTEGRAVIR AND EFAVIRENZ (ABSTRACT
82)
Rulan Griesel
University of Cape Town, Cape Town, Western Cape, South Africa
CHANGES IN BODY MASS INDEX AND THE RISK OF CARDIOVASCULAR DISEASE: THE D:A:D STUDY (ABSTRACT
83)
Kathy Petoumenos
The Kirby Institute, UNSW Sydney, Sydney, Australia
LOSARTAN TO REDUCE INFLAMMATION AND FIBROSIS ENDPOINTS IN HIV DISEASE (LIFE-HIV) (ABSTRACT
84)
Jason V Baker
Hennepin Healthcare Research Institute, Minneapolis, MN, USA
EFFECTS OF HIV INFECTION AND IMMUNE REGULATION ON LONGITUDINAL LUNG FUNCTION DECLINE (ABSTRACT
85)
Jing Sun
Johns Hopkins University, Baltimore, MD, USA
AZITHROMYCIN FOR TREATMENT OF HIV-RELATED CHRONIC LUNG DISEASE IN AFRICAN CHILDREN (ABSTRACT
86)
Rashida Abbas Ferrand
London School of Hygiene and Tropical Medicine, London, United Kingdom
TARGETING THE KSHV TYROSINE KINASE AND VIRAL LYTIC REACTIVATION WITH INHIBITORS (ABSTRACT
64)
Thomas F. Schulz
Medizinische Hochschule Hannover, Hannover, Germany
A ROLE FOR IRON METABOLISM AND FERROPTOSIS IN KAPOSI SARCOMA HERPESVIRUS PATHOGENESIS (ABSTRACT
65)
Ashlee Vivien Moses
Oregon Health & Science University, Beaverton, OR, USA
GENE EXPRESSION PATTERNS IN SKIN VS GASTROINTESTINAL KAPOSI SARCOMA LESIONS (ABSTRACT
66)
Joseph Ziegelbauer
National Institutes of Health, Bethesda, MD, USA
IMPACT OF VALGANCICLOVIR THERAPY ON SEVERE IRIS–KAPOSI SARCOMA–ATTRIBUTABLE MORTALITY (ABSTRACT
67)
Patricia Volkow
Instituto Nacional de Cancerologia, Mexico City, Mexico
SURVEILLANCE OF RHESUS MACAQUE TISSUES IDENTIFYING GAMMAHERPESVIRUS INFECTION SITES (ABSTRACT
68)
Catherine Brands
Frederick National Laboratory for Cancer Research, Frederick, MD, USA
CONJUNCTIVAL CANCER IN PEOPLE LIVING WITH HIV: THE SAM STUDY (ABSTRACT
69)
Tafadzwa G Dhokotera
Institute of Social and Preventative Medicine, University of Bern, Switzerland, Bern, Switzerland
CLEARANCE OF HPV ANAL HIGH-GRADE INTRAEPITHELIAL LESIONS WITH LOW-DOSE POMALIDOMIDE (ABSTRACT
70)
Mark Polizzotto
The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia
INCREASED CANCER RISK WITH LOWER CD4/CD8 RATIO AMONG ADULTS WITH HIV IN NA-ACCORD (ABSTRACT
71)
Jessica L. Castilho
Vanderbilt University Medical Center, Nashville, TN, USA
BIC/FTC/TAF POSTEXPOSURE PROPHYLAXIS PROTECTS MACAQUES AGAINST RECTAL SHIV INFECTION (ABSTRACT
87)
Elena Bekerman
Gilead Sciences Inc, Foster City, CA, USA
ON-DEMAND HIV POSTEXPOSURE PROPHYLAXIS BY TAF/EVG VAGINAL INSERTS IN MACAQUES (ABSTRACT
88)
Charles Dobard
CDC, atlanta, GA, USA
WEEKLY ORAL ISLATRAVIR PROVIDES EFFECTIVE PEP AGAINST IV CHALLENGE WITH SIVMAC251 (ABSTRACT
89)
Jay Grobler
Merck & Co, West Point, PA, USA
PHASE I PLACEBO-CONTROLED SAFETY, PK, AND PD STUDY OF MB66 ANTI-HIV AND ANTI-HSV FILM (ABSTRACT
90)
Susan Cu-Uvin
The MIriam Hospital, Providence, RI, USA
NEAR-PERFECT ACCURACY OF A REAL-TIME URINE TENOFOVIR TEST COMPARED TO LAB-BASED ELISA (ABSTRACT
91)
Matthew A Spinelli
University of California San Francisco, San Francisco, CA, USA
LONGER-TERM SAFETY OF F/TAF AND F/TDF FOR HIV PREP: DISCOVER TRIAL WEEK-96 RESULTS (ABSTRACT
92)
Onyema Ogbuagu
Yale School of Medicine, New Haven, CT, USA
INITIATING PREP DURING ACUTE HIV INFECTION: WHAT IS THE RISK FOR ARV DRUG RESISTANCE? (ABSTRACT
93)
Donn J Colby
Thai Red Cross AIDS Research Centre, Seattle, WA, USA
PEPFAR DREAMS INTERVENTION AMONG ADOLESCENT GIRLS AND YOUNG WOMEN IN RAKAI, UGANDA (ABSTRACT
94)
Hadijja Nakawooya
Rakai Health Sciences Program, KALISIZO TOWN, Uganda
WHOLE-BODY PET IMAGING OF THE HIV RESERVOIR USING RADIOLABELED VRC01 (ABSTRACT
72)
Timothy J Henrich
UCSF, San Francisco, CA, USA
ANTIGEN-DRIVEN CLONAL SELECTION SHAPES THE FATE OF HIV-INFECTED CD4+ T CELLS IN VIVO (ABSTRACT
73)
Francesco Roberto Simonetti
Johns Hopkins University, Baltimore, MD, USA
DISTINCT CHROMOSOMAL INTEGRATION SITE CONFIGURATION IN HIV-1 ELITE CONTROLLERS (ABSTRACT
74)
Chenyang Jiang
Brigham and Women's Hospital, Cambridge, MA, USA
INTACT PROVIRAL DNA LEVELS DECLINE IN PEOPLE WITH HIV ON ANTIRETROVIRAL THERAPY (ABSTRACT
75)
Rajesh T Gandhi
Massachusetts General Hospital, Boston, MA, USA
CHIMERIC ANTIGEN RECEPTOR T CELLS CONTROL SHIV REPLICATION IN POST-ATI MACAQUES (ABSTRACT
76)
Blake Rust
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
DELAY IN VIRAL REBOUND WITH TLR7 AGONIST, N6-LS, AND PGT121 IN SHIV-INFECTED MACAQUES (ABSTRACT
77)
Denise C Hsu
US Military HIV Research Program, Bangkok, Thailand
COMBINED ACTIVE AND PASSIVE IMMUNIZATION IN SHIV-INFECTED RHESUS MONKEYS (ABSTRACT
78)
Dan Barouch
Beth Israel Deaconess Medical Center, Boston, MA, USA
COMBINATION IL-15 THERAPY IN A SHIV NHP MODEL (ABSTRACT
79)
James Whitney
Beth Israel Deaconess Medical Center, Boston, MA, USA
GLOBAL EPIDEMIOLOGY AND PREVENTION OF COVID-19
John T Brooks
Centers for Disease Control and Prevention, Atlanta, GA, USA
VIROLOGY OF CORONAVIRUSES
Ralph S Baric
University of North Carolina Chapel Hill, Chapel Hill, NC, USA
OUTBREAK OF COVID-19 IN CHINA AND THE COUNTRY'S RESPONSES
Zunyou Wu
THE RESEARCH RESPONSE TO COVID-19: A VIEW FROM NIAID
Anthony S Fauci
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
SESSION INTRODUCTION
Avindra Nath
National Institutes of Health, Bethesda, MD, USA
CONSERVED CSF HIV ANTIBODY RESPONSE IN PATIENTS WITH DIVERSE NEUROLOGIC PHENOTYPES (ABSTRACT
405)
Isobel Anne Hawes
University of California San Francisco, San Francisco, CA, USA
CNS HIV BEARS ENVELOPE MARKERS CONSISTENT WITH T-CELL ORIGIN IN THE FACE OF ART (ABSTRACT
424)
Alex Sigal
Africa Health Research Institute (AHRI), Durban, KwaZulu-Natal, South Africa
RETINAL THINNING CORRELATES WITH BRAIN ATROPHY IN WELL-CONTROLLED HIV INFECTION (ABSTRACT
418)
Bryan Smith
National institutes of Health, Bethesda, MD, USA
BIOMARKERS OF NUCLEIC ACID OXIDATION AND NEURODEGENERATION IN CSF IN PWH (ABSTRACT
411)
Ronald J. Ellis
University of California, San Diego, CA, USA
PREDICTIVE VALIDATION OF AN UGANDAN INFANT EYE-TRACKING TEST OF MEMORY OF HUMAN FACES (ABSTRACT
412)
Michael Joseph Boivin
Michigan State University, East Lansing, MI, USA
SESSION INTRODUCTION
Sari L Reisner
Harvard T.H. Chan School of Public Health, Boston, MA, USA
PREEXPOSURE PROPHYLAXIS ADHERENCE AND PERSISTENCE IN KENYAN TRANSGENDER WOMEN AND MSM (ABSTRACT
878)
Makobu Kimani
Kenya Medical Research Institute (KEMRI), Kilifi, Kenya
HIV PREVALENCE AND RISK IN MALE‚ TRANSMALE, AND TRANSFEMALE SEX WORKERS IN ZIMBABWE
Jan Anton Charles Hontelez
Erasmus University Medical Center, Rotterdam, Netherlands
FACTORS ASSOCIATED WITH HIV, HCV, AND HSV-2 SEROSTATUS AMONG US TRANSGENDER WOMEN (ABSTRACT
880)
Morgan P Keruly
NIH, Baltimore, MD, USA
<< first | < prev
page:
of 3
|
records per page:
next >
| last >>
|
pages: 1 2 3
|
presentations:
1 to
50 of
111
|